Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment

Aydiner, Adnan; Sen, Fatma; Tambas, Makbule; Ciftci, Rumeysa; Eralp, Yeşim; Saip, Pinar; Karanlik, Hasan; Fayda, Merdan; Kucucuk, Seden; Onder, Semen; Yavuz, Ekrem; Muslumanoglu, Mahmut; Igci, Abdullah

doi:10.1097/md.0000000000002341

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment

Atıf İçin Kopyala

Aydiner A., Sen F., Tambas M., Ciftci R., Eralp Y., Saip P., ...Daha Fazla

MEDICINE, cilt.94, sa.52, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 94 Sayı: 52
Basım Tarihi: 2015
Doi Numarası: 10.1097/md.0000000000002341
Dergi Adı: MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
İstanbul Üniversitesi Adresli: Evet

Özet

Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, and prognosis. The purpose of this study was to compare patients with MBC with clinicopathologic and treatment-matched patients with triple-negative breast carcinoma (TNBC) in terms of response to treatment, progression, and survival.